Characterization of psychiatric admissions in Huntington disease: A retrospective review

Shuhei Shiino1, Sarah Moroz2, Jeffrey Stovall3

  • 1Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.

Insights

Psychiatric crises are frequent in Huntington disease (HD), often requiring hospitalization. This study highlights the need for better emergency psychiatric care and integrated management strategies for HD patients.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Neuropsychiatric symptoms are prevalent in Huntington disease (HD).
  • Existing guidelines for inpatient psychiatric treatment in HD are lacking.
  • Mental health emergencies are common in HD patients.

Purpose of the Study:

  • To analyze psychiatric hospitalizations in Huntington disease (HD) patients.
  • To understand the mental health needs of HD patients.
  • To identify gaps in psychiatric care for HD.

Main Methods:

  • Retrospective chart review of HD patients admitted to psychiatry from 2013-2020.
  • Data extraction from electronic health records.
  • Analysis of admission indications, treatments, and follow-up care.

Main Results:

  • 11.1% of HD patients experienced at least one psychiatric hospitalization.
  • Common admission reasons included suicidal ideation/attempt, psychosis, and aggression.
  • Most patients returned to their prior care level, but readmissions were frequent.

Conclusions:

  • Psychiatric crises in HD are frequent and severe.
  • Expanded emergency psychiatric care access is needed for HD patients.
  • Further research should focus on integrated, disease-specific management of psychiatric symptoms in HD.
Abstract

Related Concept Videos

Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
152
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
458